Follow the ANAPTYSBIO, INC. share price and the full insider trade history of the company, a listed issuer based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). The latest transaction was disclosed on 13 July 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: DENNIS MULROY. All data is openly available.
16
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,584 of 28,899 companies
15.1
score / 100
Value
24
Quality
6
FCF yld-3.6%
Earn yld-4.5%
EV/EBITDA·
ROE-40%
Gross mgn·
Net mgn-55%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
ANAPTYSBIO, INC. is a biopharmaceutical company focused on developing antibody-based therapies for autoimmune diseases and cancer. It is listed on NASDAQ under the ticker ANAB.